Similar Items: Addressing challenges in the treatment of tuberculosis and tuberculosis meningitis: a pharmacometric approach
- Advancing tuberculosis treatment through pharmacometric modeling of drug exposure and biomarkers
- Pharmacometrics to characterize pharmacokinetics and optimize treatment in understudied populations
- Pharmacometrics of dolutegravir and tenofovir: a quantitative approach to characterise drug-drug interactions, pharmacogenetics and optimise treatment
- Pharmacometric modelling to inform and improve TB and HIV treatment: Focus on drug-drug interactions and neglected populations
- Population pharmacokinetic and pharmacodynamic modelling to improve tuberculosis treatment
- Simultaneous quantification of first-line anti-tuberculosis drugs and metabolites in human plasma
Author: Denti, Paolo
- Pharmacometric modelling to inform and improve TB and HIV treatment: Focus on drug-drug interactions and neglected populations
- Pharmacokinetics, pharmacogenetics and optimisation of treatment with non-nucleoside reverse transcriptase inhibitors in HIV-infected African children
- Population pharmacokinetic modelling to optimise treatment for children with Rifampicin-resistant TB and HIV
- Population pharmacokinetic and pharmacodynamic modelling to improve tuberculosis treatment
- A scoping review on the use of telerehabilitation in physiotherapy in low and middle income countries
- Advancing tuberculosis treatment through pharmacometric modeling of drug exposure and biomarkers